Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000228270 | SCV000291725 | likely benign | DICER1-related tumor predisposition | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002255338 | SCV002533080 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-09-05 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV002465601 | SCV002760795 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002255338 | SCV004848982 | uncertain significance | Hereditary cancer-predisposing syndrome | 2016-11-23 | criteria provided, single submitter | clinical testing | The c.734+6C>T intronic alteration consists of a C to T substitution nucleotides after coding exon 5 in the DICER1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003967670 | SCV004782207 | likely benign | DICER1-related disorder | 2023-03-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |